Forcyte Biotechnologies

Discover drugs that control how much cells "squeeze" to treat disease

Based based in Los Angeles, CA, USA, Forcyte Biotechnologies works in healthcare.

Profile

In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease.

We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery, to help find better drugs for mechanical diseases.

We screen 100,000s of drugs against numerous contractile human cell types to comprehensively map human mechanobiology (the "contractome") and identify promising drug development starting points to deliver novel medicines to treat mechanically-driven diseases including asthma, hypertension, preterm labor, fibrosis, and others.

Within the healthcare space, the company focuses on its core offering rather than a broad product line.

The company is recorded as being based in Los Angeles, CA, USA.

It is recorded at the Winter 2021 stage.

Recorded headcount: 5 employees.

Website: forcytebio.com